"Virus Activation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.
| Descriptor ID |
D014775
|
| MeSH Number(s) |
G06.920.925.940
|
| Concept/Terms |
Virus Activation- Virus Activation
- Activation, Virus
- Activations, Virus
- Virus Activations
- Viral Activation
- Activation, Viral
- Activations, Viral
- Viral Activations
- Virus Induction
- Induction, Virus
- Inductions, Virus
- Virus Inductions
Prophage Induction- Prophage Induction
- Induction, Prophage
- Inductions, Prophage
- Prophage Inductions
Prophage Excision- Prophage Excision
- Excision, Prophage
- Excisions, Prophage
- Prophage Excisions
|
Below are MeSH descriptors whose meaning is more general than "Virus Activation".
Below are MeSH descriptors whose meaning is more specific than "Virus Activation".
This graph shows the total number of publications written about "Virus Activation" by people in this website by year, and whether "Virus Activation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Virus Activation" by people in Profiles.
-
?-catenin regulates HIV latency and modulates HIV reactivation. PLoS Pathog. 2022 03; 18(3):e1010354.
-
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021 06 29; 12(1):3922.
-
BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation. Transpl Immunol. 2015 Mar; 32(2):116-20.
-
Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant. 2014 Jul; 20(7):992-9.
-
Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
-
Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J Virol. 2008 Mar; 82(6):2813-20.
-
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003 Sep 23; 61(6):775-82.
-
Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood. 2002 May 01; 99(9):3310-8.
-
Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication. AIDS. 2001 Mar 09; 15(4):441-9.
-
Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis. 2000 May; 181(5):1574-80.